Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Executive & Enterprise Communications will serve as a trusted communications advisor to the CEO and select senior leaders while leading enterprise internal communications across a growing global organization. This is a high-impact role for a communicator who can operate strategically and execute with excellence. Success in this position requires sound judgment, executive presence, strong writing skills, and the ability to move seamlessly between shaping a CEO keynote and building the communications infrastructure that keeps teams informed, aligned, and engaged. Reporting to the Head of Communications, this role partners closely with the Corporate Communications lead, the Associate Director of Internal Communications, and regional communications and HR partners globally. This is a rare opportunity to work directly with RevMed’s executive leadership team, shaping executive voice, internal culture, and enterprise communications at a company rapidly building toward commercial stage.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior